Dr. Satya Prakash
Dr. Satya Prakash
Professor of Biomedical Engineering, Faculty of Medicine, McGill University
Verified email at mcgill.ca
TitleCited byYear
Early enteral nutrition in severe acute pancreatitis: a prospective randomized controlled trial comparing nasojejunal and nasogastric routes
A Kumar, N Singh, S Prakash, A Saraya, YK Joshi
Journal of clinical gastroenterology 40 (5), 431-434, 2006
3252006
Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic …
ML Jones, CJ Martoni, M Parent, S Prakash
British Journal of Nutrition 107 (10), 1505-1513, 2012
2342012
Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapy
S Prakash, M Malhotra, W Shao, C Tomaro-Duchesneau, S Abbasi
Advanced drug delivery reviews 63 (14-15), 1340-1351, 2011
2152011
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of …
GA Roth, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ...
The Lancet 392 (10159), 1736-1788, 2018
2112018
Microencapsulated genetically engineered live E. coli DH5 cells administered orally to maintain normal plasma urea level in uremic rats
S Prakash, TMS Chang
Nature medicine 2 (8), 883, 1996
2061996
Nonsteroidal anti-inflammatory drugs, disease-modifying antirheumatic drugs, nonopioid analgesics, and drugs used in gout
DE Furst, RW Ulrich, C Varkey-Altamirano
Basic and clinical pharmacology 8, 596-624, 2001
1962001
Gut microbiota: next frontier in understanding human health and development of biotherapeutics
S Prakash, L Rodes, M Coussa-Charley, C Tomaro-Duchesneau
Biologics: targets & therapy 5, 71, 2011
1862011
Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial
ML Jones, CJ Martoni, S Prakash
European journal of clinical nutrition 66 (11), 1234, 2012
1792012
Vanadium: a review of its potential role in the fight against diabetes
V Badmaev, S Prakash, M Majeed
The Journal of Alternative and Complementary Medicine 5 (3), 273-291, 1999
1751999
A randomised controlled trial of high-dose isoniazid adjuvant therapy for multidrug-resistant tuberculosis
SK Katiyar, S Bihari, S Prakash, M Mamtani, H Kulkarni
The international journal of tuberculosis and lung disease 12 (2), 139-145, 2008
1682008
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
M Martin, FA Holmes, B Ejlertsen, S Delaloge, B Moy, H Iwata, ...
The Lancet Oncology 18 (12), 1688-1700, 2017
1602017
Locking without blocking: making lock based concurrent data structure algorithms nonblocking
J Turek, D Shasha, S Prakash
Proceedings of the eleventh ACM SIGACT-SIGMOD-SIGART symposium on Principles …, 1992
1451992
MPI-SIM: using parallel simulation to evaluate MPI programs
S Prakash, RL Bagrodia
1998 Winter Simulation Conference. Proceedings (Cat. No. 98CH36274) 1, 467-474, 1998
1391998
Bone marrow stem cell derived paracrine factors for regenerative medicine: current perspectives and therapeutic potential
TJ Burdon, A Paul, N Noiseux, S Prakash, D Shum-Tim
Bone marrow research 2011, 2011
1382011
A nonblocking algorithm for shared queues using compare-and-swap
S Prakash, YH Lee, T Johnson
IEEE Transactions on Computers 43 (5), 548-559, 1994
1381994
Designing a broad-spectrum integrative approach for cancer prevention and treatment
KI Block, C Gyllenhaal, L Lowe, A Amedei, ARMR Amin, A Amin, ...
Seminars in cancer biology 35, S276-S304, 2015
1332015
Complements and the wound healing cascade: an updated review
H Sinno, S Prakash
Plastic surgery international 2013, 2013
1332013
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic …
SL James, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ...
The Lancet 392 (10159), 1789-1858, 2018
1302018
Therapeutic uses of microencapsulated genetically engineered cells
TMS Chang, S Prakash
Molecular Medicine Today 4 (5), 221-227, 1998
1251998
Synthesis of TAT peptide-tagged PEGylated chitosan nanoparticles for siRNA delivery targeting neurodegenerative diseases
M Malhotra, C Tomaro-Duchesneau, S Prakash
Biomaterials 34 (4), 1270-1280, 2013
1232013
The system can't perform the operation now. Try again later.
Articles 1–20